Javascript must be enabled to continue!
Contemporary diagnosis and management of gallbladder polyps
View through CrossRef
Gallbladder (GB) polyps are present in 5%–10% of the general population and consist of true neoplastic polyps (adenomas) and pseudopolyps (predominantly cholesterol, inflammatory, hyperplastic, focal adenomyomatosis). True polyps, although relatively rare neoplastic lesions (0.5%) are considered an important factor in malignant transformation and cancer development (5%) when their size is ≥ 1 cm. Given that it is essential to diagnose GB adenocarcinoma at an early stage to optimize therapeutic management, controversy exists about whether cholecystectomy is always necessary. Their imaging characteristics, size ≥ 1 cm, age > 50 years and genetic predisposition determine the indications for immediate cholecystectomy. In younger patients with polyps < 1 cm in size and without a familial history of GB carcinoma, imaging follow-up by ultrasound (US) seems to be a reasonable recommended policy. A scoring system by multivariate analysis (cross-sectional area > 123 mm2, positive blood flow signal, age > 55.5 years, alanine aminotransferase (ALT) levels > 50 U/L and an ALT/AST (aspartate aminotransferase) ratio > 0.77) can accurately predict true polyps. The widely accepted size threshold for US follow-up is 7 mm, and for intervention, it is 10 mm. Computed tomography or better magnetic resonance imaging can overcome any misdiagnosis of conventional US incidental findings alone that may lead to potentially unnecessary operations. In challenging cases, high-resolution US, novel three-dimensional US, endoscopic US or contrast-enhanced endoscopic US could be helpful. Novel microflow imaging can safely predict polyps. Risk factors for malignancy include age > 60 years, large gallstones, primary sclerosing cholangitis, Asian ethnicity and sessile polyps accompanied by focal gallbladder wall thickening > 4 mm. For polyps sized 6–9 mm, the absence of growth at recommended follow-up (6 months, one year, and two years) indicates treatment discontinuation; however, it is not required for size < 5 mm without risk factors. In addition to laparoscopic cholecystectomy, the standard management, novel interventional modalities preserving the GB in selected cases include per-oral transmural endoscopic resection of GB polyps after a bridge of endoscopic US-guided cholecystostomy or laparoscopic gallbladder-preserving polypectomy. Generally, there are still no precise and strong evidence-based guidelines; thus, the management policy of GB polyps should be individualized in ambiguous cases.
Scholar Media Publishing
Title: Contemporary diagnosis and management of gallbladder polyps
Description:
Gallbladder (GB) polyps are present in 5%–10% of the general population and consist of true neoplastic polyps (adenomas) and pseudopolyps (predominantly cholesterol, inflammatory, hyperplastic, focal adenomyomatosis).
True polyps, although relatively rare neoplastic lesions (0.
5%) are considered an important factor in malignant transformation and cancer development (5%) when their size is ≥ 1 cm.
Given that it is essential to diagnose GB adenocarcinoma at an early stage to optimize therapeutic management, controversy exists about whether cholecystectomy is always necessary.
Their imaging characteristics, size ≥ 1 cm, age > 50 years and genetic predisposition determine the indications for immediate cholecystectomy.
In younger patients with polyps < 1 cm in size and without a familial history of GB carcinoma, imaging follow-up by ultrasound (US) seems to be a reasonable recommended policy.
A scoring system by multivariate analysis (cross-sectional area > 123 mm2, positive blood flow signal, age > 55.
5 years, alanine aminotransferase (ALT) levels > 50 U/L and an ALT/AST (aspartate aminotransferase) ratio > 0.
77) can accurately predict true polyps.
The widely accepted size threshold for US follow-up is 7 mm, and for intervention, it is 10 mm.
Computed tomography or better magnetic resonance imaging can overcome any misdiagnosis of conventional US incidental findings alone that may lead to potentially unnecessary operations.
In challenging cases, high-resolution US, novel three-dimensional US, endoscopic US or contrast-enhanced endoscopic US could be helpful.
Novel microflow imaging can safely predict polyps.
Risk factors for malignancy include age > 60 years, large gallstones, primary sclerosing cholangitis, Asian ethnicity and sessile polyps accompanied by focal gallbladder wall thickening > 4 mm.
For polyps sized 6–9 mm, the absence of growth at recommended follow-up (6 months, one year, and two years) indicates treatment discontinuation; however, it is not required for size < 5 mm without risk factors.
In addition to laparoscopic cholecystectomy, the standard management, novel interventional modalities preserving the GB in selected cases include per-oral transmural endoscopic resection of GB polyps after a bridge of endoscopic US-guided cholecystostomy or laparoscopic gallbladder-preserving polypectomy.
Generally, there are still no precise and strong evidence-based guidelines; thus, the management policy of GB polyps should be individualized in ambiguous cases.
Related Results
Prevalence and Risk Factors of Gallbladder Stones and Polyps in Liaoning, China
Prevalence and Risk Factors of Gallbladder Stones and Polyps in Liaoning, China
ObjectiveTo investigate the incidence and risk factors of gallbladder stones and polyps in individuals undergoing physical examinations in Liaoning province, China.MethodsThis is a...
Relationship between gallstones and interstitial cells of Cajal in the gallbladder
Relationship between gallstones and interstitial cells of Cajal in the gallbladder
Introduction:
A high percentage of patients with gallstones exhibit abnormalities in gallbladder emptying, and gallstones are often associated with gallbladder contract...
Gastric Polyps: A 10-Year Analysis Of 18496 Upper Endoscopies
Gastric Polyps: A 10-Year Analysis Of 18496 Upper Endoscopies
Abstract
Background/Aims: Gastric polyps (GPs) are usually asymptomatic lesions of the upper gastrointestinal tract observed in 1-3% of esophagogastroduodenoscopies (EGD). ...
704 Laparoscopic Cholecystectomy for Ultrasound Proven Gallbladder Polyps – an Unsound Indication?
704 Laparoscopic Cholecystectomy for Ultrasound Proven Gallbladder Polyps – an Unsound Indication?
Abstract
Aim
Current European guidelines recommend cholecystectomy for ultrasound proven gallbladder polyps based on size. Over-...
G-EYE Colonoscopy Is Superior to Standard Colonoscopy for Increasing Adenoma/Polyp Detection Rate
G-EYE Colonoscopy Is Superior to Standard Colonoscopy for Increasing Adenoma/Polyp Detection Rate
Abstract
Background
Colorectal cancer (CRC) is one of the most common cancers worldwide. Most CRCs develop from malignant potent...
Preoperative diagnosis of gallbladder volvulus: Clinical case report and review of the literature
Preoperative diagnosis of gallbladder volvulus: Clinical case report and review of the literature
Introduction: Gallbladder volvulus is an uncommon disorder that impedes the circulation of fluid in the gallbladder and blood vessels. Gallbladder volvulus accounts for only 1 in 3...
Prevalence and risk factors of gallbladder polyps in primary health care centers among patients examined by abdominal ultrasonography in Qatar: a case–control study
Prevalence and risk factors of gallbladder polyps in primary health care centers among patients examined by abdominal ultrasonography in Qatar: a case–control study
Background: Gallbladder (GB) polyps are raised lesions from the GB wall and projected into its lumen. The prevalence of GB polyps ranged between 4.3% and 12.3%. The clinical presen...
Gastric polyps: a 10-year analysis of 18,496 upper endoscopies
Gastric polyps: a 10-year analysis of 18,496 upper endoscopies
Abstract
Background/aims
Gastric polyps (GPs) are usually asymptomatic lesions of the upper gastrointestinal tract observed in 1–3% of esophagogastr...

